Incretin hormone glucagon-like peptide-1 (GLP-1) are gut-derived hormones that can stimulate insulin secretion, and GLP-1 secretion in patients with T2DM is deficient resulting in promoting the process of T2DM [19]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.